Individuals with obesity exhibit an almost 70% reduction in ADRB2 sensitivity (Reynisdottir et al., 1994; Schiffelers et al., 2001) and a 50% reduction in the number of ADRB2 positive adipocytes in obesity and hyperinsulinemia (Hagberg et al., 2018). This evidence concerns the gene ADRB2 and Hyperinsulinemia.